ACS Omega,
Journal Year:
2024,
Volume and Issue:
9(39), P. 40592 - 40607
Published: Sept. 20, 2024
This
study
introduces
a
novel,
environmentally
friendly
albumin
isolation
method
using
graphene
oxide
(GO).
GO
selectively
extracts
from
serum
samples,
leveraging
the
unique
interactions
between
GO's
oxygen-containing
functional
groups
and
proteins.
achieves
high
purification
efficiency
without
need
for
hazardous
chemicals.
Comprehensive
characterization
of
reduced
(rGO)
through
techniques
such
as
X-ray
diffraction
(XRD)
analysis,
Raman
spectroscopy,
scanning
electron
microscopy
(SEM),
Fourier
transform
infrared
spectroscopy
(FTIR)
confirmed
structural
group
transformations
crucial
protein
binding.
Sodium
dodecyl
sulfate-polyacrylamide
gel
electrophoresis
(SDS-PAGE)
mass
spectrometry
analyses
demonstrated
over
95%
purity
isolated
albumin,
with
minimal
contamination
other
The
developed
method,
optimized
pH
incubation
conditions,
showcases
green,
cost-effective,
simple
alternative
purification,
promising
broad
applicability
in
biomedical
research
clinical
applications.
Journal for Research in Applied Sciences and Biotechnology,
Journal Year:
2024,
Volume and Issue:
3(1), P. 7 - 11
Published: Feb. 1, 2024
The
quest
for
precision
medicine
hinges
on
targeted
drug
delivery,
minimizing
off-target
effects
while
maximizing
therapeutic
impact.
Among
nanocarriers,
albumin
–
the
most
abundant
protein
in
human
blood
emerges
as
a
uniquely
biocompatible
stealth
bomber.
Its
inherent
advantages,
including
exceptional
biodegradability,
prolonged
circulation,
and
natural
affinity
diseased
tissues,
perfectly
align
with
goals
of
personalized
medicine.
Albumin
readily
solubilizes
poorly
soluble
drugs,
enhancing
bioavailability
broadening
arsenal.
versatile
surface
allows
modifications,
enabling
dual
diagnosis
treatment
(theranostics)
tailored
to
individual
needs.
While
challenges
remain
optimizing
loading
targeting
specificity,
albumin-based
nanocarriers
hold
immense
promise
revolutionizing
healthcare,
delivering
potent
therapeutics
pinpoint
accuracy.
burgeoning
field
nanodrug
delivery
seeks
redefine
landscapes
by
engineering
nanoscale
carriers
that
meticulously
deliver
drugs
their
designated
targets,
systemic
exposure
efficacy.
This
pursuit
aligns
medicine,
where
treatments
demand
exquisite
control
over
delivery.
Within
this
intricate
choreography,
albumin,
resident
plasma,
maestro,
orchestrating
symphony
advantages
make
it
prime
candidate
nanocarrier
construction.
Pharmaceutics,
Journal Year:
2024,
Volume and Issue:
16(4), P. 533 - 533
Published: April 12, 2024
Dendrimers,
intricate
macromolecules
with
highly
branched
nanostructures,
offer
unique
attributes
including
precise
control
over
size,
shape,
and
functionality,
making
them
promising
candidates
for
a
wide
range
of
biomedical
applications.
The
exploration
their
interaction
biological
environments,
particularly
human
serum
albumin
(HSA),
holds
significant
importance
utilization.
In
this
study,
the
between
HSA
recently
developed
self-assembling
amphiphilic
dendrimer
(AD)
was
investigated
using
various
experimental
techniques.
Fluorescence
spectroscopy
isothermal
titration
calorimetry
revealed
moderate
interactions
protein
AD
nanomicelles
(NMs),
primarily
attributed
to
favorable
enthalpic
contributions
arising
from
electrostatic
hydrogen
bonding.
Structural
analysis
indicated
minimal
changes
in
upon
complexation
NMs,
which
further
supported
by
computational
simulations
demonstrating
stable
at
atomistic
level.
These
findings
provide
valuable
insights
into
binding
mechanisms
thermodynamic
parameters
governing
HSA/AD
NM
interactions,
thereby
contributing
understanding
potential
International Journal of Nanomedicine,
Journal Year:
2024,
Volume and Issue:
Volume 19, P. 5581 - 5603
Published: June 1, 2024
Lenvatinib
(LVN)
is
a
potentially
effective
multiple-targeted
receptor
tyrosine
kinase
inhibitor
approved
for
treating
hepatocellular
carcinoma,
metastatic
renal
cell
carcinoma
and
thyroid
cancer.
Nonetheless,
poor
pharmacokinetic
properties
including
water
solubility
rapid
metabolic,
complex
tumor
microenvironment,
drug
resistance
have
impeded
its
satisfactory
therapeutic
efficacy.
This
article
comprehensively
reviews
the
uses
of
nanotechnology
in
LVN
to
improve
antitumor
effects.
With
characteristic
high
modifiability
loading
capacity
nano-drug
delivery
system,
an
active
targeting
approach,
controllable
release,
biomimetic
strategies
been
devised
deliver
target
tumors
sequence,
compensating
lack
passive
targeting.
The
existing
applications
advances
improving
efficacy
include
longer-term
efficiency,
achieving
higher
combination
therapy,
tracking
diagnosing
application
reducing
toxicity.
Therefore,
using
multiple
combined
with
photothermal,
photodynamic,
immunoregulatory
therapies
overcomes
multi-drug
resistance,
regulates
unfavorable
yields
synergistic
In
brief,
nano-LVN
system
has
brought
light
war
against
cancer
while
at
same
time
effect.
More
intelligent
multifunctional
nanoparticles
should
be
investigated
further
converted
into
clinical
future.
Aggregate,
Journal Year:
2024,
Volume and Issue:
unknown
Published: Aug. 2, 2024
Abstract
Photodynamic
therapy
is
a
highly
recommended
alternative
treatment
for
solid
tumors,
such
as
cutaneous
or
luminal
in
clinical
practice.
However,
conventional
photosensitizers
(PSs)
often
induce
undesirable
phototoxic
effects
because
of
their
normal
tissue
distribution
and
reduction
antitumor
resulting
from
aggregation‐caused
quenching
effects.
The
present
study
developed
novel
nano‐formulated
aggregation‐induced
emission
(AIE)‐characteristic
PS,
nab‐TTVPHE,
which
composed
human
serum
albumin
carrier
TTVPHE
therapeutic
agent,
more
effective
cancer
with
lower
Notably,
the
reactive
oxygen
species
generated
by
were
shielded
nanoaggregate
structure,
photodynamic
activity
was
after
nanostructure
dissociation.
Nab‐TTVPHE
actively
internalized
tumor
cells
via
secreted
protein,
acidic
rich
cysteine
released
to
form
nanoaggregates.
accumulated
mitochondria,
where
it
triggered
mitochondrial
damage
under
light
irradiation
its
induced
pyroptosis
caspase‐3/gasdermin
E
(GSDME)
signaling
pathway
kill
cells.
Therefore,
this
AIE‐characteristic
PS
provides
an
innovative
strategy
effect
ability
boost
potential
immunity
GSDME‐mediated
pyroptosis.
Pharmacological Research - Modern Chinese Medicine,
Journal Year:
2024,
Volume and Issue:
11, P. 100447 - 100447
Published: May 21, 2024
In
recent
years,
there
has
been
a
growing
interest
in
leveraging
traditional
medicinal
plants
for
modern
therapeutic
approaches,
particularly
cancer
treatment.
The
review
explores
the
potential
of
Camptotheca
acuminata,
Chinese
plant,
treatment
through
innovative
phytonano-based
drug
delivery
systems.
acuminata
contains
camptothecin,
potent
anticancer
compound,
but
its
use
is
hindered
by
poor
solubility,
bioavailability,
and
systemic
toxicity.
study
highlights
how
phytonano-technology
can
enhance
accuracy
reduce
side
effects
using
nanoparticles
to
encapsulate
selectively
deliver
drugs
directly
cells.
This
approach
could
significantly
improve
oncology
therapy
addressing
limitations
chemotherapy.
Using
PubMed
Scopus,
prospective
research
on
activities
several
mushroom
species
during
past
20
years
were
searched.
query
included
"Camptotheca
acuminata,"
"cancer,"
"nanoparticles,"
"traditional
medicine,"
"theranostics."
Only
entire
English-language
articles
used.
Phytonano-Cancer
Theranostics
with
camptothecin
effectively
targets
cells,
showing
substantial
uptake
vitro
prolonged
circulation
accumulation
at
tumor
sites
vivo.
These
results
demonstrate
precise
effective
therapy.
integration
offers
promising
targeted
theranostic
capabilities
However,
challenges
remain,
including
optimizing
nanoparticle
design
stability,
scalability,
biocompatibility,
overcoming
biological
barriers
efficient
targeting.
Addressing
these
requires
interdisciplinary
maximize
strategies
patient
outcomes.
Karbala International Journal of Modern Science,
Journal Year:
2024,
Volume and Issue:
10(2)
Published: June 8, 2024
Human
serum
albumin
(HSA)
nanoparticles
have
been
widely
used
as
versatile
drug
delivery
systems
for
improving
the
efficiency
and
pharmaceutical
properties
of
drugs.
The
present
study
aimed
to
design
HSA
nanoparticle
encapsulated
with
hydrophobic
anticancer
pyridine
derivative
(2-((2-([1,1'-biphenyl]-4-yl)imidazo[1,2-a]pyrimidin-3-yl)methylene)hydrazine-1-carbothioamide
(BIPHC)).
synthesis
HSA-BIPHC
was
achieved
using
a
desolvation
process.
Atomic
force
microscopy
(AFM)
analysis
showed
average
size
80.21
nm.
percentages
entrapment
efficacy,
loading
capacity
production
yield
were
98.11%,
9.77%
91.29%,
respectively.
An
In
vitro
release
revealed
that
displayed
fast
dissolution
at
pH
7.4
compared
3.4.
They
also
higher
cytotoxic
activity
against
MCF-7
human
breast
cancer
cells.
possible
binding
BIPHC
into
tyrosine
threonine
kinase
(TTK)
studied
molecular
modeling.
findings
this
introduced
promising
candidate
model
delivering
drug.
These
novel
are
characterized
by
their
ability
carry
agent
control
improved
targeting
International Journal of Molecular Sciences,
Journal Year:
2024,
Volume and Issue:
25(15), P. 8045 - 8045
Published: July 24, 2024
Oxidative
stress
is
a
major
source
of
ROS-mediated
damage
to
macromolecules,
tissues,
and
the
whole
body.
It
an
important
marker
in
severe
picture
pathological
conditions.
The
discovery
free
radicals
biological
systems
gives
"start"
studying
various
processes
related
development
progression
many
diseases.
From
this
moment
on,
enrichment
knowledge
about
participation
free-radical
pathogenesis
cardiovascular,
neurodegenerative,
endocrine
diseases,
inflammatory
conditions,
infections,
including
COVID-19,
increasing
exponentially.
Excessive
responses
abnormal
reactive
oxygen
species
(ROS)
levels
may
disrupt
mitochondrial
dynamics,
risk
cell
damage.
In
addition,
low
serum
albumin
changes
normal
physiological
balance
between
reduced
oxidized
can
be
serious
prerequisite
for
impaired
antioxidant
capacity
body,
worsening
condition
patients.
This
review
presents
interrelationship
oxidative
stress,
inflammation,
levels,
which
are
hallmarks
COVID-19.
Journal of drug targeting,
Journal Year:
2024,
Volume and Issue:
unknown, P. 1 - 19
Published: June 7, 2024
The
high
recurrence
rate
of
hepatocellular
carcinoma
(HCC)
and
poor
prognosis
after
medical
treatment
reflects
the
necessity
to
improve
current
chemotherapy
protocols,
particularly
drug
delivery
methods.
Development
targeted
efficient
systems
(DDSs),
in
all
active,
passive
stimuli-responsive
forms
for
selective
therapeutic
drugs
tumour
site
has
been
extended
efficacy
reduce
severe
side
effects.
Recent
advances
nanotechnology
offer
promising
breakthroughs
diagnosis,
monitoring
cancer
cells.
In
this
review,
specific
design
DDSs
based
on
different
nano-particles
their
surface
engineering
is
discussed.
addition,
innovative
clinical
studies
which
nano-based
DDS
was
used
HCC
were
highlighted.